Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Boston Scientific
Electromedical and Electrotherapeutic Apparatus ManufacturingUnited StatesNYSE: BSX
Last verified 2 months agobostonscientific.com
Boston Scientific Corporation, a leading name in the electromedical and electrotherapeutic apparatus manufacturing industry, is headquartered in the United States. Founded in 1979, the company has established itself as a pioneer in developing innovative medical devices that enhance patient care across various therapeutic areas, including cardiology, urology, and endoscopy.
With a strong presence in North America, Europe, and Asia, Boston Scientific is renowned for its cutting-edge products, such as stents, catheters, and neuromodulation devices. These offerings are distinguished by their advanced technology and commitment to improving patient outcomes. The company has achieved significant milestones, including numerous FDA approvals and recognitions for its contributions to healthcare innovation, solidifying its position as a trusted leader in the medical device sector.
80
DitchCarbon score
+13 vs industry average
Boston Scientific’s score of 80 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Boston Scientific?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Electromedical and Electrotherapeutic Apparatus Manufacturing has below-average carbon intensity
Industry performance
0.330
20182025
The Electromedical and Electrotherapeutic Apparatus Manufacturing industry has reduced its overall emissions by 28% since 2018
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Boston Scientific's reported carbon emissions
Boston Scientific Corporation, a US-based Electromedical and Electrotherapeutic Apparatus Manufacturing company, reported its latest carbon emissions data for 2024. The company's total emissions for 2024 were approximately 1,757,966,000 kg CO2e. This included Scope 1 emissions of 87,567,000 kg CO2e, Scope 2 market-based emissions of 9,854,000 kg CO2e, and Scope 3 emissions of 1,663,859,000 kg CO2e.
Boston Scientific has set ambitious climate commitments, with Science Based Targets initiative (SBTi) approved targets. The company aims for net-zero greenhouse gas emissions across its value chain by 2050, from a 2019 base year. For near-term targets, Boston Scientific commits to reducing absolute Scope 1 and 2 GHG emissions by 46.2% by 2030, also from a 2019 base year. Additionally, the company plans to reduce Scope 3 GHG emissions from purchased goods and services, capital goods, fuel and energy-related activities, upstream transportation and distribution, and business travel by 55% per USD value added by 2030, using a 2019 base year. Long-term, Boston Scientific targets a 97% reduction in Scope 1 and 2 GHG emissions per USD value added (equivalent to a 90% absolute reduction) by 2050, and a 97% reduction in Scope 3 GHG emissions per USD value added by 2050, both from a 2019 base year. The company is also committed to achieving carbon neutrality in all manufacturing and key distribution sites by 2030.
Assessing Boston Scientific as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Boston Scientific and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Boston Scientific’s Climate Goals (2030 & 2050)
10 goals2050
97% reduction in scope 3 total
Boston Scientific Corporation also commits to reduce scope 3 GHG emissions 97.0% per USD value added by 2050 from a 2024 base year.
Insufficient data97%
2050
90% reduction in Scope 1
Boston Scientific Corporation commits to reduce absolute scope 1 GHG emissions 97.0% by 2050 from a 2019 base year.
Insufficient data90%
2050
90% reduction in Scope 2
Boston Scientific Corporation commits to reduce absolute scope 2 GHG emissions 97.0% by 2050 from a 2019 base year.
Insufficient data90%
See all 10 climate goals
Sign up to see all goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
12 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
2030 targetSee details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Boston Scientific2 months ago
80
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Boston Scientific’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more